Some parts of the portal may cause error messages or display incorrectly due to the transition to a new provider of trading data

SNTI - Senti Biosciences Inc.


IEX Last Trade
2.65
-0.060   -2.264%

Share volume: 6,992
Last Updated: Fri 30 Aug 2024 09:53:22 PM CEST
Research and Development in Biotechnology (except Nanobiotechnology): 0.21%

PREVIOUS CLOSE
CHG
CHG%

$2.71
-0.06
-2.21%
5D - 1M - 3M - 1Y - 3Y - 5Y - 10Y - 15Y
Income statement Balance sheet Cash flow To see more then 2 years history Buy Premium
View ratios

Fiscal Date 2023-03-31 2023-06-30 2023-09-30 2023-12-31 2024-03-31
Fiscal Quarter Q1 2023 Q2 2023 Q3 2023 Q4 2023 Q1 2024
Report Date 2023-05-09 2023-08-11 2023-11-14 2024-03-21 2024-05-09
Assets
Total Assets 161.425 M 143.630 M 131.766 M 119.484 M 102.185 M
Current Assets 80.511 M 63.492 M 79.007 M 71.200 M 55.666 M
Inventories 0.000 0.000 0.000 0.000 0.000
Other Current Assets 3.614 M 3.290 M 20.957 M 17.570 M 14.020 M
Short Term Investments 3.614 M 3.290 M 20.957 M 17.570 M 14.020 M
Total Receivables 791.000 K 567.000 K 18.620 M 17.704 M 17.923 M
Current Cash 76.106 M 59.635 M 39.430 M 35.926 M 23.723 M
Total Non-current Assets 80.914 M 80.138 M 52.759 M 48.284 M 46.519 M
Property Plant Equipment 58.987 M 58.940 M 26.433 M 25.338 M 24.354 M
Other Assets 18.376 M 17.862 M 18.251 M 17.608 M 16.266 M
Intangible Assets 0.000 0.000 0.000 0.000 0.000
Goodwill 0.000 0.000 0.000 0.000 0.000
Liabilities and shareholders’ equity
Total Liabilities and shareholders’ equity 161.425 M 143.630 M 131.766 M 119.484 M 102.185 M
Total liabilities 49.085 M 46.214 M 48.830 M 52.571 M 46.091 M
Total current liabilities 12.866 M 10.426 M 10.114 M 12.672 M 9.609 M
Accounts Payable 2.582 M 2.585 M 1.991 M 1.250 M 1.624 M
Other liabilities 280.000 K 99.000 K 4.085 M 6.361 M 4.037 M
Current long term debt 2.151 M 2.551 M 2.682 M 4.128 M 4.278 M
Long term debt 35.939 M 35.689 M 34.631 M 33.538 M 32.445 M
Other liabilities 280.000 K 99.000 K 4.085 M 6.361 M 4.037 M
Minority interest 0.000 0.000 0.000 0.000 0.000
Total Shareholder equity 112.340 M 97.416 M 82.936 M 66.913 M 56.094 M
Common stock 44.071 M 44.278 M 44.473 M 44.666 M 45.709 M
Retained earnings -192.008 M -210.705 M -225.628 M -244.344 M -256.455 M